羚锐制药：董事、副总经理陈燕拟减持不超20万股股份

Core Viewpoint - The company Lingrui Pharmaceutical (600285.SH) announced that its director and deputy general manager, Chen Yan, plans to reduce her holdings by no more than 200,000 shares due to personal financial needs [1] Summary by Relevant Sections Shareholding Reduction Plan - Chen Yan intends to sell up to 200,000 shares, which represents approximately 0.0353% of the company's total share capital and no more than 25% of her total shareholding [1] - The reduction will occur within three months following the announcement, excluding a trading window where no sales will take place [1] - The selling price will be determined based on the market price at the time of the sale [1]